US$ 21.95
glp 1 drug coverage Designing fiscally viable of GLP-1 weight-loss drugs GLP-1 Costs Explained: Managing Coverage
Description
The IIH treatment trial assessed 165 patients with IIH, treated either with acetazolamide or placebo in addition to a low sodium weight reduction diet

Beyond clinical efficacy, the company that secures uninterrupted global supply and manufacturing scale could dominate the market

References Heymsfield, S

Demand for these drugs has been so high that it has led to ongoing shortages and even boosted Denmarks GDP last year
